tokens: In the present study we prospectively compared side effects occurring in 12 patients after the first administration of low - dose OKT3 ( 0 . 5 mg twice daily ) induction therapy with those in 10 patients who were treated with a conventional dose of OKT3 ( 5 mg daily ) for acute rejection .